Vital Images (Plymouth, MN) and R2 Technology announced at the RSNA meeting a deal to integrate Vital Images' flagship software product Vitrea 2 with R2's ImageChecker CT software for the detection of lung nodules. Under the three-year agreement, the
Vital Images (Plymouth, MN) and R2 Technology announced at the RSNA meeting a deal to integrate Vital Images' flagship software product Vitrea 2 with R2's ImageChecker CT software for the detection of lung nodules. Under the three-year agreement, the integrated software will be distributed worldwide outside Japan, pending required regulatory approvals. The FDA has not yet approved ImageChecker CT software.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.